U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229560) titled 'A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants' on Nov. 13.
Brief Summary: This is a phase I study to evaluate the effect of Itraconazole on the pharmacokinetics of HRS-8080 in healthy participants and the safety of HRS-8080 administered alone and in combination with Itraconazole in healthy participants.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervention:
DRUG: HRS-8080 Tablet
HRS-8080 tablet, specified dose on specified days.
DRUG: Itraconazole Capsule
Itraconazole capsule, specified dose on specified days.
Recruitment Status: NOT_YET_RECRUITI...